On February 5, 2021, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,280 KRW | 0.00% | -8.96% | -23.49% |
1st Jan change | Capi. | |
---|---|---|
-23.49% | 67.03M | |
-15.31% | 189B | |
+1.23% | 167B | |
+3.80% | 157B | |
+4.33% | 102B | |
+35.91% | 85.01B | |
+10.16% | 83.93B | |
-4.92% | 73.3B | |
-24.07% | 52.32B | |
-7.35% | 44.09B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd.